Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00389376Phase 1Completed
Phase I Trial of Silymarin for Chronic Liver Diseases
Hepatitis CNon-Alcoholic Fatty Liver Disease
Principalinvestigator

Research Network

Collaboration Network

20 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of North Carolina

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen A. Harrison, MD

Brooke Army Medical Center

Moderately Similar
16 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease
Similarity Score30%

Marc G Ghany, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Moderately Similar
14 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score30%

Nezam Afdhal, MD

Beth Israel Deaconess Medical Center

Related
5 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Center for Complementary and Integrative Health (NCCIH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

Victor Navarro, MD

Thomas Jefferson University

Related
3 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Center for Complementary and Integrative Health (NCCIH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

K. Rajender Reddy, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

Hepatitis CNon-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Center for Complementary and Integrative Health (NCCIH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

Mahmoud Alalfy

Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Related
14 trials

Shared therapeutic areas:

Hepatitis C
Similarity Score15%

Salomé Pérez

University of Navarra

Related
3 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score15%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease
Similarity Score15%

Sonia Caprio, MD

Yale University

Related
9 trials

Shared therapeutic areas:

Non-alcoholic Fatty Liver Disease

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Shih-Jer Hsu, MD

National Taiwan University Hospital, Yun-Lin Branch

Related
5 trials

Shared therapeutic areas:

Hepatitis C
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00389376Phase 1PrincipalInvestigator

Phase I Trial of Silymarin for Chronic Liver Diseases

Hepatitis CNon-Alcoholic Fatty Liver Disease
Completed

All 1 trials loaded